NCT04493853 2026-01-20
CAPItello-281
AstraZeneca
Phase 3 Active not recruiting
Clinical Trials
6 trialsNCT05593497 2025-04-16
SNARE
VA Office of Research and Development
Phase 2 Recruiting
NCT05348577 2025-01-27
CAPItello280
AstraZeneca
Phase 3 Active not recruiting
NCT03310541 2023-05-06
AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT04087174 2022-07-13
A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer
AstraZeneca
Phase 1 Completed
NCT02121639 2022-05-05
ProCAID
University Hospital Southampton NHS Foundation Trust
Phase 1/2 Completed